IL21 and systemic sclerosis: In experimental SSc, the blockade of IL-21 or of inducible T cell co-stimulator ICOS (expressed by TFH) resulted in decreased skin fibrosis establishing a link between TFH cells and an immune-mediated fibrotic reaction [156, 157].